RSH 24.4% 5.6¢ respiri limited

Ann: Shareholder teleconference presentation, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 37 Posts.
    lightbulb Created with Sketch. 18
    further Jackson the key milestone which just about all industry players and practitioners have highlighted as the key company making moment for us is the study of wheeze vs the stethoscope - this gives us the scientific proof to allow the practitioners to endorse us and start to recommend us vs the outdated, not accurate and difficult to use peak-flow-meter - this will be far more material and important for the success of this company vs any marketing or social media strategy. The company has had to play a very delicate balance of not making too much “noise” before this study has been complete.

    i think even the keyboard warriors amongst us will be amazed as to the awareness strategies that will be put in place once these medical requirements have been ticked off.

 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.